 |
|
Obstructive Sleep Apnea
Jay F. Piccirillo, MD;
Stephen Duntley, MD;
Helena Schotland, MD
JAMA. 2000;284:1492-1494.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
INTRODUCTION
Obstructive sleep apnea (OSA) syndrome affects an estimated 2% to 4% of the US adult population.1 It is part of a collection of sleep-related breathing disorders, that include snoring, upper airway resistance syndrome,2 and obesity-hypoventilation syndrome.3 The clinical sequelae of untreated OSA syndrome are often severe and include daytime hypersomnolence, cognitive impairment, systemic hypertension, pulmonary hypertension, myocardial infarction, cardiac arrhythmias, and increased risk of motor vehicle crashes.4-5 Unfortunately, the majority of patients with OSA syndrome remain undiagnosed and untreated.6
Identification of Patients With OSA
Haponik et al7 evaluated how frequently primary care physicians, medical interns, and medical interns who had received prior instruction concerning sleep disorders asked about sleep during simulated patient interviews. They found that none of the experienced primary care physicians and only 13% of the medical interns inquired about sleep disorders. In contrast, 82% of medical interns with prior sleep instruction asked . . . [Full Text of this Article]
Diagnostic Testing
Treatment
Author Affiliations: Departments of Otolaryngology-Head and Neck Surgery (Dr Piccirillo), Neurology (Dr Duntley), and Medicine (Dr Schotland), and the Division of Pulmonary and Critical Care Medicine (Dr Schotland), Washington University School of Medicine, St Louis, Mo.
RELATED ARTICLE
September 27, 2000
JAMA. 2000;284(12):1587-1588.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
The Impact of Postoperative Nasal Packing on Sleep-Disordered Breathing and Nocturnal Oxygen Saturation in Patients with Obstructive Sleep Apnea Syndrome
Regli et al.
Anesth. Analg. 2006;102:615-620.
ABSTRACT
| FULL TEXT
|
